December 07, 2016

Boehringer Ingelheim Vetmedica, Inc. Names 2016 Research Award Recipients

BIVI funds five, $15,000 awards to study equine infectious disease.

Boehringer Ingelheim Vetmedica, Inc. (BIVI) is pleased to announce the recipients of the 2016 Advancement in Equine Research Awards. These awards are given annually to researchers who are advancing research towards equine infectious diseases. This year BIVI funded five awards of $15,000 each.

"BIVI knows that the future of animal health lies in further understanding infectious diseases, as well as infectious disease prevention measures," says Steve Grubbs, DVM, PhD, DACVIM, equine technical manager for BIVI. "We will continue to support research studies as they contribute to our future understanding of infectious diseases and their management."

BIVI congratulates the 2016 research award recipients for the following projects:

  • Bud C. Tennant, DVM, DACVIM at Cornell University, for"Transmission of newly discovered equine hepatitis-associated viruses of horses"
  • Macarena Sanz, DVM, MS, PhD, DACVIM at Washington State University, for:
    • "Evaluation of EM and RT-PCR to detect equine coronavirus in fecal samples of horses admitted to a veterinary teaching hospital"
    • "Effect of intravenous R. equi-specific hyperimmune plasma administration on fecal shedding of pathogenic R. equi after experimental infection of newborn foals"
  • Connie Gebhart, MS, PhD at University of Minnesota, for"Equine Proliferative Enteropathy- In vitro antimicrobial activity against two equine Lawsonia intracellularis isolates"
  • Nicola Pusterla, DVM, PhD, DACVIM, Dept. Med and Epi, SVM, at UC Davis, for "Investigation of the shedding of respiratory pathogens in healthy horses presented for the routine dental care"

Researchers receiving the grants are studying a wide array of equine infectious diseases. Dr. Nicola Pusterla, at the University of California, Davis, will focus his current research award on the frequency of detection of infectious respiratory viruses in subclinically infected horses that are brought in for routine dental care.

"The award has allowed our research group to investigate various relevant and timely aspects of these infectious diseases," Dr. Pusterla says. "I am a believer of small grants to either generate pilot data or answer clinically relevant questions. Unfortunately, research grant opportunities are sparse in equine medicine, despite great diseases to focus on. We are blessed in the equine field to have such great and continuous support from BIVI."

Multi-year award winner, Dr. Macarena Sanz, says that she has used her research award grants to understand how infectious diseases affect young foals in the first six months of life.

"As an equine internist, I face every day the important and sometimes devastating role that infectious diseases have in young foals," Dr. Sanz says. "The Advancement in Equine Research Awards provides my laboratory with the invaluable ability to generate preliminary data. This type of data is key to further our understanding of infectious disease and immune response that occurs in consequence. As a result of these preliminary studies, new areas for future research continue to develop."

Since 2011, BIVI has awarded more than $450,000 to the Advancement in Equine Research Awards. Veterinarians, diagnosticians, as well as public and private researchers in the United States and Canada are eligible to submit proposals for research programs that help advance the diagnosis, treatment and understanding of equine infectious disease. Awards are selected based on established criteria, including potential impact on the equine industry; originality and scientific quality; and probability of success in completing the year-long studies.

Information for the 2017 Advancement in Equine Research Awards will be available in June 2017. For more information, and for submission instructions, please visit

For more information, please contact:

Stephanie Hoult,
PR Account Supervisor, broadhead